ALLMedicine™ Keratoconjunctivitis Sicca Center

Apr 12th, 2022 - For the purposes of determining the prevalence of ocular complications in inflammatory rheumatic diseases, the following search terms were used: conjunctivitis, keratoconjunctivitis sicca, xerophthalmia, uveitis, eye hemorrhage, optic neuritis, pa...

Mar 26th, 2022 - To report on microbial keratitis (MK) in three scleral lens (SL) wearers who had undergone penetrating keratoplasty (PKP). This retrospective case series describes 3 cases of MK in patients who wore SLs after PKP. All three patients wore SLs for v...

Feb 25th, 2022 - Background A red eye is a cardinal sign of ocular inflammation, which can result from many conditions. Subconjunctival hemorrhage (see the image below), defined as blood between the conjunctiva and the sclera, is usually not secondary to inflammat...

Jan 27th, 2022 - Sucralfate is an aluminum salt of sucrose octasulfate, generally considered safe in terms of adverse effects. Systemic sucralfate is FDA-approved for the treatment of duodenal ulcers. Since 1991, topical sucralfate has been used in various mucocut...

Jan 15th, 2022 - A 41-year-old female presented with dysgeusia, dry eyes, nyctalopia with progressive visual field constriction (due to autoimmune retinopathy) and gastrointestinal symptoms (due to ulcerative colitis). She was subsequently admitted to intensive ca...

Apr 12th, 2022 - For the purposes of determining the prevalence of ocular complications in inflammatory rheumatic diseases, the following search terms were used: conjunctivitis, keratoconjunctivitis sicca, xerophthalmia, uveitis, eye hemorrhage, optic neuritis, pa...

Oct 7th, 2021 - Fuchs Endothelial Corneal Dystrophy (FECD) is the most common corneal endothelial disorder and has been estimated to affect approximately 4% of the US population over the age of 40. Corneal transplantation is currently the primary treatment modali...

Apr 8th, 2021 - Keratoconjunctivitis sicca, also known as dry eye syndrome, is one of the most common ophthalmological diseases and is treated with tear substitutes to moisten the surface of the eye and, in more severe cases of this disease, with local anti-infla...

May 27th, 2020 - This study evaluates the efficacy and safety of 2 doses of pimecrolimus (0.3% and 1%) ophthalmic suspension in a moderate to severe population of keratoconjunctivitis sicca (KCS, dry eye syndrome) patients.

Feb 11th, 2020 - The purpose of the study is to evaluate how treatment with Intra-Nasal Mechanical Stimulation (INMEST) in the nasal cavity in patients with Keratoconjunctivitis sicca can relieve these symtoms.

Feb 3rd, 2022 - The US Food and Drug Administration (FDA) has approved the first generic of cyclosporine ophthalmic emulsion (Restasis) to treat keratoconjunctivitis sicca (dry eye). Restasis has been approved by the FDA since 2003 and works to help increase tear...

Jan 29th, 2020 - Recognizing the patterns of joint involvement seen in psoriatic arthritis is essential to its diagnosis. Five patterns have been identified. They are: Asymmetrical oligoarticular arthritis Symmetrical polyarthritis Arthritis mutilans Distal interp...

Aug 17th, 2018 - The US Food and Drug Administration (FDA) has approved cyclosporine A ophthalmic solution 0.09% (Cequa, Sun Pharmaceuticals) to increase tear production in patients with keratoconjunctivitis sicca (dry eye), the company has announced. Cequa is a p...

Sep 29th, 2017 - Dry eye disease, also known as keratoconjunctivitis sicca and keratitis sicca, is a multifactorial disease of the tears and the ocular surface that results in discomfort, visual disturbance, and tear film instability. Dry eye disease is a common f...

Sep 29th, 2017 - Dry eye disease, also known as keratoconjunctivitis sicca and keratitis sicca, is a multifactorial disease of the tears and the ocular surface that results in discomfort, visual disturbance, and tear film instability. Dry eye disease is a common f...